FibroBiologics, Inc. (FBLG) Operating cash flow 2022–2025
FibroBiologics, Inc. (FBLG) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$16.4MFY2025 · since FY2022: -$4.1M → -$16.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.4M | -37.8% |
| FY2024 | -$11.9M | -85.9% |
| FY2023 | -$6.4M | -57.4% |
| FY2022 | -$4.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FBLG financial trends
FBLG RevenueFBLG Net incomeFBLG Net marginFBLG Gross profitFBLG Gross marginFBLG Operating incomeFBLG Operating marginFBLG Free cash flowFBLG Capital expendituresFBLG Return on equityFBLG Stock buybacksFBLG Dividends paidFBLG Total assetsFBLG Total liabilitiesFBLG Shareholders’ equityFBLG overview →